A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy

Condition: Obesity and GlomerulopathyInterventions: Drug: High dosage Sevelamer Carbonate + Irbesartan; Drug: Low dosage Sevelamer Carbonate + Irbesartan; Drug: IrbesartanSponsor: Zhi-Hong Liu, M.D.Not yet recruiting - verified December 2015

http://clinicaltrials.gov/ct2/show/NCT02644486?lup_s=12%2F16%2F2015&lup_d=30

Source: ClinicalTrials.gov - December 30, 2015 Category: Research Source Type: clinical trials